High-Sensitivity C-Reactive Protein Can Reflect Small Airway Obstruction in Childhood Asthma
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: High-sensitivity assays enabled the identification of C-reactive protein (hs-CRP) at levels that were previously undetectable. We aimed to determine if hs-CRP could reflect airway inflammation in children, by comparing hs-CRP with spirometry and impulse oscillometry (IOS) parameters and symptomatic severities. Materials and Methods: A total of 276 asthmatic children who visited Severance Children’s Hospital from 2012–2014 were enrolled. Serum hs-CRP and pulmonary function tests were performed on the same day. Patients were divided into hs-CRP positive and negative groups (cut-off value, 3.0 mg/L). Results: Of the 276 asthmatic children [median age 7.5 (5.9/10.1) years, 171 boys (62%)], 39 were hs-CRP positive and 237 were negative. Regarding spirometry parameters, we observed significant differences in maximum mid-expiratory flow, % predicted (FEF25–75) (p=0.010) between hs-CRP positive and negative groups, and a negative correlation between FEF25–75 and hs-CRP. There were significant differences in the reactance area (AX) (p=0.046), difference between resistance at 5 Hz and 20 Hz (R5–R20) (p=0.027), resistance at 5 Hz, % predicted (R5) (p=0.027), and reactance at 5 Hz, % predicted (X5) (p=0.041) between hs-CRP positiveand negative groups. There were significant positive correlations between hs-CRP and R5 (r=0.163, p=0.008), and X5 (r=0.164, p=0.007). Spirometry and IOS parameters had more relevance in patients with higher blood neutrophil levels in comparison to hs-CRP. Conclusion: Hs-CRP showed significant correlation with FEF25–75, R5, and X5. It can reflect small airway obstruction in childhood asthma, and it is more prominent in neutrophil dominant inflammation.
Abstract
Purpose: High-sensitivity assays enabled the identification of C-reactive protein (hs-CRP) at levels that were previously undetectable. We aimed to determine if hs-CRP could reflect airway inflammation in children, by comparing hs-CRP with spirometry and impulse oscillometry (IOS) parameters and symptomatic severities. Materials and Methods: A total of 276 asthmatic children who visited Severance Children’s Hospital from 2012–2014 were enrolled. Serum hs-CRP and pulmonary function tests were performed on the same day. Patients were divided into hs-CRP positive and negative groups (cut-off value, 3.0 mg/L). Results: Of the 276 asthmatic children [median age 7.5 (5.9/10.1) years, 171 boys (62%)], 39 were hs-CRP positive and 237 were negative. Regarding spirometry parameters, we observed significant differences in maximum mid-expiratory flow, % predicted (FEF25–75) (p=0.010) between hs-CRP positive and negative groups, and a negative correlation between FEF25–75 and hs-CRP. There were significant differences in the reactance area (AX) (p=0.046), difference between resistance at 5 Hz and 20 Hz (R5–R20) (p=0.027), resistance at 5 Hz, % predicted (R5) (p=0.027), and reactance at 5 Hz, % predicted (X5) (p=0.041) between hs-CRP positiveand negative groups. There were significant positive correlations between hs-CRP and R5 (r=0.163, p=0.008), and X5 (r=0.164, p=0.007). Spirometry and IOS parameters had more relevance in patients with higher blood neutrophil levels in comparison to hs-CRP. Conclusion: Hs-CRP showed significant correlation with FEF25–75, R5, and X5. It can reflect small airway obstruction in childhood asthma, and it is more prominent in neutrophil dominant inflammation.
참고문헌 (39)
- van de Kant KD, "Early diagnosis of asthma in young children by using non-invasive biomarkers of airway inflammation and early lung function measurements: study protocol of a case-control study", BMC Public Health, 9, pp.210~ (2009)
- Deraz TE, "High-sensitivity C reactive protein as a biomarker for grading of childhood asthma in relation to clinical classification, induced sputum cellularity, and spirometry", Pediatr Pulmonol, 47, pp.220~225 (2012)
- Busse WW, "Asthma", N Engl J Med, 344, pp.350~362 (2001)
- Jousilahti P, "The association of sensitive systemic inflammation markers with bronchial asthma", Ann Allergy Asthma Immunol, 89, pp.381~385 (2002)
- Hoshino M, "Increased C-reactive protein is associated with airway wall thickness in steroid-naive asthma", Ann Allergy Asthma Immunol, 113, pp.37~41 (2014)
- Ramirez D, "Assessment of high-sensitivity C-reactive protein as a marker of airway inflammation in asthma", Ann Allergy Asthma Immunol, 104, pp.485~489 (2010)
- Kilic H, "The relationship between hs-CRP and asthma control test in asthmatic patients", Allergol Immunopathol (Madr), 40, pp.362~367 (2012)
- Ridker PM, "High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease", Circulation, 103, pp.1813~1818 (2001)
- Takemura M, "High sensitivity C-reactive protein in asthma", Eur Respir J, 27, pp.908~912 (2006)
- Shimoda T, "Serum high-sensitivity C-reactive protein can be an airway inflammation predictor in bronchial asthma", Allergy Asthma Proc, 36, pp.e23~e28 (2015)
- Rifai N, "Clinical effcacy of an automated highsensitivity C-reactive protein assay", Clin Chem, 45, pp.2136~2141 (1999)
- Sahoo RC, "A study of high-sensitivity C-reactive protein in bronchial asthma", Indian J Chest Dis Allied Sci, 51, pp.213~216 (2009)
- Zietkowski Z, "High-sensitivity C-reactive protein in the exhaled breath condensate and serum in stable and unstable asthma", Respir Med, 103, pp.379~385 (2009)
- Sävykoski T, "Chlamydia pneumoniae infection and inflammation in adults with asthma", Respiration, 71, pp.120~125 (2004)
- Kony S, "Association of bronchial hyperresponsiveness and lung function with C-reactive protein (CRP): a population based study", Thorax, 59, pp.892~896 (2004)
- Fujita M, "C-reactive protein levels in the serum of asthmatic patients", Ann Allergy Asthma Immunol, 99, pp.48~53 (2007)
- Shaaban R, "Change in C-reactive protein levels and FEV1 decline: a longitudinal population-based study", Respir Med, 100, pp.2112~2120 (2006)
- Olafsdottir IS, "C reactive protein levels are increased in non-allergic but not allergic asthma: a multicentre epidemiological study", Thorax, 60, pp.451~454 (2005)
- Navratil M, "Markers of systemic and lung inflammation in childhood asthma", J Asthma, 46, pp.822~828 (2009)
- Crapo RO, "Guidelines for methacholine and exercise challenge testing-1999. This offcial statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999", Am J Respir Crit Care Med, 161, pp.309~329 (2000)
- Pearson TA, "Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association", Circulation, 107, pp.499~511 (2003)
- Greenland P, "2010 ACCF", AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation, Circulation, pp.2010, 122[DOI]
- Goldman MD., "Clinical application of forced oscillation", Pulm Pharmacol Ther, 14, pp.341~350 (2001)
- Komarow HD, "Impulse oscillometry in the evaluation of diseases of the airways in children", Ann Allergy Asthma Immunol, 106, pp.191~199 (2011)
- Pepys MB, "C-reactive protein fifty years on", Lancet, 1, pp.653~657 (1981)
- Pepys MB, "Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein", Adv Immunol, 34, pp.141~212 (1983)
- Gabay C, "Acute-phase proteins and other systemic responses to inflammation", N Engl J Med, 340, pp.448~454 (1999)
- Wouters EF, "Systemic and local inflammation in asthma and chronic obstructive pul-monary disease: is there a connection?", Proc Am Thorac Soc, 6, pp.638~647 (2009)
- Wilkinson TM, "Respiratory syncytial virus, airway inflammation, and FEV1decline in patients with chronic obstructive pulmonary disease", Am J Respir Crit Care Med, 173, pp.871~876 (2006)
- Maclay JD, "Cardiovascular risk in chronic obstructive pulmonary disease", Respirology, 12, pp.634~641 (2007)
- Livnat G, "Evaluation of high-sensitivity serum CRP levels compared to markers of airway inflammation and allergy as predictors of methacholine bronchial hyper-responsiveness in children", Lung, 193, pp.39~45 (2015)
- Weiss ST, "Effects of asthma on pulmonary function in children. A longitudinal population-based study", Am Rev Respir Dis, 145, pp.58~64 (1992)
- Rao DR, "The utility of forced expiratory flow between 25% and 75% of vital capacity in predicting childhood asthma morbidity and severity", J Asthma, 49, pp.586~592 (2012)
- Beydon N, "An offcial American Thoracic Society", European Respiratory Society statement: pulmonary function testing in preschool children, 2007, pp.175, 1304~1345
- Wood LG, "The neutrophilic inflammatory phenotype is associated with systemic inflammation in asthma", Chest, 142, pp.86~93 (2012)
- Halvani A, "Evaluation of correlation between airway and serum inflammatory markers in asthmatic patients", Lung India, 29, pp.143~146 (2012)
- Butland BK, "C-reactive protein, obesity, atopy and asthma symptoms in middle-aged adults", Eur Respir J, 32, pp.77~84 (2008)
- Barnes PJ, "Systemic manifestations and comorbidities of COPD", Eur Respir J, 33, pp.1165~1185 (2009)
- Fu JJ, "Systemic inflammation is associated with differential gene expression and airway neutrophilia in asthma", OMICS, 17, pp.187~199 (2013)